|
Name |
3'-O-Methyldehydroisopenicillide
|
Molecular Formula | C22H24O6 | |
IUPAC Name* |
6-hydroxy-1-methoxy-2-[(E)-3-methoxy-3-methylbut-1-enyl]-8-methyl-10H-benzo[b][1,5]benzodioxocin-12-one
|
|
SMILES |
CC1=CC2=C(C(=C1)O)OC3=C(C(=C(C=C3)/C=C/C(C)(C)OC)OC)C(=O)OC2
|
|
InChI |
InChI=1S/C22H24O6/c1-13-10-15-12-27-21(24)18-17(28-19(15)16(23)11-13)7-6-14(20(18)25-4)8-9-22(2,3)26-5/h6-11,23H,12H2,1-5H3/b9-8+
|
|
InChIKey |
JZRZUVUPQOWUMF-CMDGGOBGSA-N
|
|
Synonyms |
3'-O-Methyldehydroisopenicillide; CHEMBL2164948; 3-(3-Methoxy-3-methyl-1-butenyl)-4-methoxy-9-methyl-11-hydroxy-5H,7H-dibenzo[b,g][1,5]dioxocin-5-one
|
|
CAS | NA | |
PubChem CID | 9864866 | |
ChEMBL ID | CHEMBL2164948 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.4 | ALogp: | 3.7 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.742 |
Caco-2 Permeability: | -4.896 | MDCK Permeability: | 0.00001720 |
Pgp-inhibitor: | 0.767 | Pgp-substrate: | 0.097 |
Human Intestinal Absorption (HIA): | 0.049 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.046 |
Blood-Brain-Barrier Penetration (BBB): | 0.115 | Plasma Protein Binding (PPB): | 97.98% |
Volume Distribution (VD): | 0.446 | Fu: | 4.78% |
CYP1A2-inhibitor: | 0.915 | CYP1A2-substrate: | 0.869 |
CYP2C19-inhibitor: | 0.923 | CYP2C19-substrate: | 0.504 |
CYP2C9-inhibitor: | 0.755 | CYP2C9-substrate: | 0.917 |
CYP2D6-inhibitor: | 0.766 | CYP2D6-substrate: | 0.892 |
CYP3A4-inhibitor: | 0.697 | CYP3A4-substrate: | 0.755 |
Clearance (CL): | 6.011 | Half-life (T1/2): | 0.466 |
hERG Blockers: | 0.043 | Human Hepatotoxicity (H-HT): | 0.029 |
Drug-inuced Liver Injury (DILI): | 0.233 | AMES Toxicity: | 0.523 |
Rat Oral Acute Toxicity: | 0.55 | Maximum Recommended Daily Dose: | 0.663 |
Skin Sensitization: | 0.64 | Carcinogencity: | 0.927 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.666 |
Respiratory Toxicity: | 0.549 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006147 | 0.841 | D0L1JW | 0.308 | ||||
ENC004019 | 0.826 | D04TDQ | 0.296 | ||||
ENC000877 | 0.606 | D06GCK | 0.292 | ||||
ENC004018 | 0.606 | D02LZB | 0.288 | ||||
ENC001921 | 0.606 | D09DHY | 0.276 | ||||
ENC002005 | 0.590 | D0G4KG | 0.275 | ||||
ENC004016 | 0.589 | D0F7CS | 0.272 | ||||
ENC004017 | 0.589 | D0W8WB | 0.271 | ||||
ENC006148 | 0.577 | D04UTT | 0.270 | ||||
ENC002740 | 0.577 | D07MGA | 0.266 |